AIDS Treatment News - 1993
- AIDS Treatment News - 1993
- Issue #166
- VIIth International Conference on AIDS in Africa By Jason Heyman
- Announcements
- AIDS Treatments 1992/1993: Where Are We Now?
- Anabolic Steroids for Controlling Weight Loss: Australian Experience, U.S. Trial
- 1993 Nucleoside-Analog Trial Results Expected
- Issue #167
- Announcements
- CMV Experimental Treatment Overview (Part I)
- Issue #168
- New CDC Definition Now in Effect, But Confidentiality Questions Remain
- TP-5: Thymus Hormone Trial Suggests Benefit
- CMV Experimental Treatment Overview, Part II
- Announcements
- Issue #169
- Immune Restoration Conference Plans Late-Stage Treatment Research
- Issue #170
- Convergent Combination Therapy
- Announcements
- AIDS Treatment Newsletters (Continued)
- Issue #171
- Understanding Dementia and Neurologic Disorders: Interview, Elyse Singer, M. D.
- Eyesight, Hearing, Speech: Potential for Rehabilitation Often Ignored When Treating AIDS
- Issue #172
- AIDS Pathogenesis: Recent Articles On Lymph-Node Infection
- Issue #173
- Announcements
- 3TC: New Treatment Enters Major Trials
- AZT, Early Intervention, and the Concorde Controversy
- Issue #174
- Announcements
- New Kind of HIV Antiviral: Food Spice, Cancer Drug Show Activity
- Tat Drug: Parallel-Track Negotiations Status
- Issue #175
- Long-Term Survival Gains Renewed Interest at Berlin Conference
- Announcements
- Expanded Access to Experimental Drugs: Interview with David Feigal, M. D., of the FDA
- AIDS in the World: Global Report on Epidemic
- Berlin Conference Overview
- Berlin Conference -- Preliminary Checklist
- Issue #176
- Curcumin Update: Could Food Spice Be Low-Cost Antiviral?
- Fusion Toxin, New Kind of Potential AIDS Treatment, in Early Clinical Trial
- Editorial
- Action Alert: San Francisco AIDS Care in Jeopardy
- Issue #177
- Berlin Conference Overview
- Berlin: Concorde Trial Questions Early AZT Use -- Wider Implications
- HIV Immigration Ban, Travel Restrictions P Current Status
- Proposal: A Better Strategy for Developing AIDS Drugs
- Issue #178
- Berlin Treatment Leads
- Peptide T Unavailable in Buyers' Clubs
- Berlin: Long-Term Survival Studies Suggest New Treatment Strategies
- Amino Acids, Herbs, Other Supplements: FDA Proposes New Regulations, Public Comment Until August 17
- Issue #179
- Thalidomide and HIV: Background
- Issue #180
- In Memoriam: Larry Waites, M. D.
- Prophylaxis: New One-Day Sulfa Desensitization Procedure
- Issue #181
- In Memoriam: James Palazzolo
- Triple-Drug Therapy Still Worth Testing, Despite Laboratory Error
- Six-Year Diet Study: Nutrients May Reduce AIDS Risk
- Berlin Conference: HIV Miscellaneous, Part I
- Issue #182
- Announcements
- DNCB Treatment Today
- Issue #183
- Cosalane: New Approach to HIV Drug
- MEGACE Now Approved for AIDS: New Formulation
- Announcements
- Recent Journal Articles
- Issue #184
- Alternative Treatment Library Available
- Clinton Health Care Plan: Major Improvement, But Issues Remain
- L-524: New Protease Trial Recruiting
- AIDS Treatment Strategies: Interview With Lisa Capaldini, M.D.
- Announcements
- Hypericin: Oral Trial Planned
- Issue #185
- Flu Season Warning
- In Memoriam: Andrew Zysman, M.D.
- Vitamin A Deficiency Associated with Increased Death Rate
- Announcements: Recent Clinical Trials Recruiting
- Issue #186
- Prescription Drug Payment: Pharmaceutical Manufacturers' Patient Assistance Programs
- Better Viral Tests: Interview with Mark B. Feinberg, M.D., Ph.D.
- Issue #187
- CMV Anti-Sense Drug Goes into Human Trials
- Tat Inhibitor Approach Still Alive
- "Poppers" Medical Background: ACT UP Fact Sheet Available
- Announcements
- Weight Loss: A Role for Growth Hormone and Anabolic Steroids?
- Issue #188
- MAC: Results Emerging from Long-Term Research
- Kaposi's Sarcoma: Taxol, TNP-470 Trials at National Cancer Institute
- Issue #189
- Voicemail Announcement Systems for Coordination at Conferences, Elsewhere
- AIDS TREATMENT NEWS Selected Index Through December 1993, Issue #189
- IL-12: Potential Treatmentt Restores Immune Response in Laboratory Test
- Advanced AIDS: Alert for CMV Polyradiculopathy. Interview with Lawrence Drew, M.D., Ph.D.
source: AIDS Treatment News
